Product news

Share this article:

Mylan Pharmaceuticals received final approval from the FDA for its Abbreviated New Drug Application for Doxycycline Tablets, 150 mg. Doxycycline Tablets are the generic version of Par Pharmaceutical's Doxycycline Tablets, 150 mg, marketed as Adoxa  Tablets by Doak Dermatologics. Doxycycline Tablets had US sales of approximately $34 million for the 12 months ending March 31, 2007 for the 150 mg. strength. In addition to this new product strength, Mylan previously received approval and is marketing the 50 mg, 75 mg and 100 mg strengths of Doxycycline Tablets.


 

King Pharmaceuticals announced plans to discontinue Florinef (fludrocortisone acetate tablets, USP), a drug used as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease for the treatment of salt losing adrenogenital syndrome.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.